mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.036 |
0.8 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |